At Paean Bio Sciences, we offer a range of Active Pharmaceutical Ingredients (API's) for the treatment of a wide range of ailments including but not limited to Diabetes and Cancer. Our products are manufactured to the highest quality standards and undergo rigorous testing to ensure purity, potency, and safety.
We are committed to serving humanity with world class therapies across Anti Diabetics and Oncology products among other products across Key Therapeutic Areas.
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects. APIs find application in high quality drugs that treat diseases pertaining to oncology, cardiology, CNS and neurology, orthopaedic, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology. APIs can potentially create a more sustainable healthcare system by introducing more innovative products.
PBS’s global portfolio in Active Pharmaceutical Ingredient (API) aims to cater to over 200+ geographies, focussed on bringing differentiated therapies across Oncology, Diabetes and other key areas, helping underserved and under privileged populations gainfully access cutting edge healthcare.
Tacrolimus is an essential immunosuppressant used in organ transplantation to prevent rejection.
Widely used post-transplant to prevent organ rejection by suppressing the immune system.
A key player in post-transplant care, Everolimus helps maintain organ function.
Proven efficacy in preventing kidney transplant rejection and treating certain types of cancer.
Sirolimus is a critical immunosuppressant that ensures transplant success.
Known for its immunosuppressive properties, reducing the risk of organ transplant rejection.
A targeted therapy for leukemia, inhibiting abnormal cell growth.
Dasatinib is a beacon of hope for patients with leukemia, offering targeted therapy.
Effective in non-small cell lung cancer treatment by blocking specific proteins.
Erlotinib is a vital treatment option for non-small cell lung cancer patients.
Recognized for its role in managing advanced prostate cancer.
Enzalutamide is a game-changer for prostate cancer treatment.
An oral medication used to treat renal cell carcinoma and soft tissue sarcoma.
Pazopanib is instrumental in managing advanced kidney cancer.
Utilized in multiple myeloma and myelodysplastic syndromes therapy.
Palbociclib is a crucial player in advanced breast cancer therapy.
Pazopanib is another valuable option for cancer patients.
Erlotinib offers hope to those battling pancreatic cancer.
Dabigatran is essential for preventing strokes and blood clots. An anticoagulant that prevents blood clots, reducing the risk of stroke and deep vein thrombosis.
Apixaban contributes to safer anticoagulation therapy. An oral anticoagulant primarily prescribed to prevent blood clots in conditions like atrial fibrillation.
Edoxaban is a significant addition to anticoagulant options. Effective in reducing the risk of stroke in patients with atrial fibrillation and treating deep vein thrombosis.